Cargando…

Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review

Molecular imaging of pathologic lesions can improve efficient detection of cancer and cardiovascular diseases. A shared pathophysiological feature is angiogenesis, the formation of new blood vessels. Endoglin (CD105) is a coreceptor for ligands of the Transforming Growth Factor-β (TGF-β) family and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sier, Vincent Q., van der Vorst, Joost R., Quax, Paul H. A., de Vries, Margreet R., Zonoobi, Elham, Vahrmeijer, Alexander L., Dekkers, Ilona A., de Geus-Oei, Lioe-Fee, Smits, Anke M., Cai, Weibo, Sier, Cornelis F. M., Goumans, Marie José T. H., Hawinkels, Lukas J. A. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124553/ https://www.ncbi.nlm.nih.gov/pubmed/33946583 http://dx.doi.org/10.3390/ijms22094804

Ejemplares similares

Cell-Based Tracers as Trojan Horses for Image-Guided Surgery
por: Sier, Vincent Q., et al.
Publicado: (2021)

Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009)

Endoglin: Beyond the Endothelium
por: Schoonderwoerd, Mark J. A., et al.
Publicado: (2020)

Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging
por: Houvast, Ruben D., et al.
Publicado: (2020)

BMP Receptor Inhibition Enhances Tissue Repair in Endoglin Heterozygous Mice
por: Bakker, Wineke, et al.
Publicado: (2021)

Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer
por: Baart, V. M., et al.
Publicado: (2020)

Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery
por: Stammes, Marieke A., et al.
Publicado: (2017)

Shear induced collateral artery growth modulated by endoglin but not by ALK1
por: Seghers, Leonard, et al.
Publicado: (2012)

Identification of CD105 (endoglin) as novel risk marker in CLL
por: Greiner, Sarah M., et al.
Publicado: (2022)

Predictive and prognostic value of FDG-PET
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2008)

Visualization of Murine Vascular Remodeling and Blood Flow Dynamics by Ultra-High-Frequency Ultrasound Imaging
por: Sier, Vincent Q., et al.
Publicado: (2022)

Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma
por: Poels, Thomas T., et al.
Publicado: (2021)

Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
por: Di Paolo, Virginia, et al.
Publicado: (2018)

CD105 (Endoglin) as negative prognostic factor in AML
por: Kauer, Joseph, et al.
Publicado: (2019)

Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins
por: Boonstra, Martin C., et al.
Publicado: (2016)

Editorial on Special Issue “Quantitative PET and SPECT”
por: van Velden, Floris H. P., et al.
Publicado: (2022)

CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy
por: Linders, Daan, et al.
Publicado: (2021)

Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy
por: van Dam, Martijn A., et al.
Publicado: (2021)

Interfering in the ALK1 Pathway Results in Macrophage-Driven Outward Remodeling of Murine Vein Grafts
por: de Jong, Alwin, et al.
Publicado: (2022)

Study of expression of endoglin (CD105) in oral squamous cell carcinoma
por: Mahapatra, Niva, et al.
Publicado: (2021)

Endoglin Targeting: Lessons Learned and Questions That Remain
por: Liu, Yingmiao, et al.
Publicado: (2020)

Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma
por: Gilles, Rozemarie, et al.
Publicado: (2011)

Endoglin and squamous cell carcinomas
por: Hakuno, Sarah K., et al.
Publicado: (2023)

Methodological considerations in quantification of oncological FDG PET studies
por: Vriens, Dennis, et al.
Publicado: (2009)

Horoscopic role of CD105 (Endoglin) in progression of oral lichen planus: An immunohistochemical study
por: Parvathala, Poornima, et al.
Publicado: (2021)

Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
por: Kasprzak, Aldona, et al.
Publicado: (2018)

Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer
por: Nogués, Ana, et al.
Publicado: (2020)

Colorectal polyps: Targets for fluorescence‐guided endoscopy to detect high‐grade dysplasia and T1 colorectal cancer
por: Dekkers, Nik, et al.
Publicado: (2023)

Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma
por: Yu, Decai, et al.
Publicado: (2007)

Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status
por: Bock, Annika J., et al.
Publicado: (2011)

ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours
por: Gromova, Petra, et al.
Publicado: (2012)

Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis
por: Ollauri-Ibáñez, Claudia, et al.
Publicado: (2020)

Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?
por: Ollauri-Ibáñez, Claudia, et al.
Publicado: (2021)

Endoglin (CD105) and proliferation index in recurrent glioblastoma treated with anti-angiogenic therapy
por: Bastos, António G. P., et al.
Publicado: (2022)

PET/CT in Patients with Breast Cancer Treated with Immunotherapy
por: Vaz, Sofia C., et al.
Publicado: (2023)

FDG-PET/CT based response-adapted treatment
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2012)

Prostate-specific membrane antigen (PSMA) as a potential target for molecular imaging and treatment in bone and soft tissue sarcomas
por: Kleiburg, Fleur, et al.
Publicado: (2023)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

Adding the temporal domain to PET radiomic features
por: Noortman, Wyanne A., et al.
Publicado: (2020)

Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer
por: Fonsatti, Ester, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_f3r8psvk84b4ri3c2l51jbtcve